Lifecore Biomedical (LFCR) Revenue & Revenue Breakdown
Lifecore Biomedical Revenue Highlights
Latest Revenue (Y)
$128.26M
Latest Revenue (Q)
$24.70M
Lifecore Biomedical Revenue by Period
Lifecore Biomedical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-05-26 | $128.26M | 24.20% |
| 2023-05-28 | $103.27M | -44.42% |
| 2022-05-29 | $185.79M | -65.86% |
| 2021-05-31 | $544.16M | -7.83% |
| 2020-05-31 | $590.37M | 5.88% |
| 2019-05-31 | $557.56M | 6.36% |
| 2018-05-31 | $524.23M | -1.51% |
| 2017-05-31 | $532.26M | -1.63% |
| 2016-05-31 | $541.10M | 0.34% |
| 2015-05-31 | $539.26M | 13.10% |
| 2014-05-31 | $476.81M | 7.95% |
| 2013-05-31 | $441.71M | 39.10% |
| 2012-05-31 | $317.55M | 14.75% |
| 2011-05-31 | $276.73M | 16.16% |
| 2010-05-31 | $238.22M | 0.97% |
| 2009-05-31 | $235.94M | -1.09% |
| 2008-05-31 | $238.53M | 13.32% |
| 2007-05-31 | $210.50M | -9.25% |
| 2006-05-31 | $231.95M | 13.02% |
| 2005-05-31 | $205.23M | 6.84% |
| 2004-05-31 | $192.09M | 100.00% |
| 2003-05-31 | - | -100.00% |
| 2002-10-31 | $183.16M | -4.05% |
| 2001-10-31 | $190.88M | -8.91% |
| 2000-10-31 | $209.55M | 491.95% |
| 1999-10-31 | $35.40M | 5.67% |
| 1998-10-31 | $33.50M | 252.63% |
| 1997-10-31 | $9.50M | 280.00% |
| 1996-10-31 | $2.50M | - |
Lifecore Biomedical generated $128.26M in revenue during NA 2024, up 24.20% compared to the previous quarter, and up 23.00% compared to the same period a year ago.
Lifecore Biomedical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-08-25 | $24.70M | -34.79% |
| 2024-05-26 | $37.89M | 6.11% |
| 2024-02-25 | $35.70M | 18.42% |
| 2023-11-26 | $30.15M | 22.95% |
| 2023-08-27 | $24.52M | -22.27% |
| 2023-05-28 | $31.55M | 14.30% |
| 2023-02-26 | $27.60M | -28.87% |
| 2022-11-27 | $38.80M | -10.50% |
| 2022-08-28 | $43.35M | -8.97% |
| 2022-05-29 | $47.63M | -10.26% |
| 2022-02-28 | $53.07M | -59.01% |
| 2021-11-30 | $129.49M | 0.55% |
| 2021-08-31 | $128.79M | -7.90% |
| 2021-05-31 | $139.83M | 1.49% |
| 2021-02-28 | $137.78M | 5.25% |
| 2020-11-30 | $130.90M | -3.49% |
| 2020-08-31 | $135.64M | -13.12% |
| 2020-05-31 | $156.13M | 2.09% |
| 2020-02-29 | $152.93M | 7.25% |
| 2019-11-30 | $142.59M | 2.80% |
| 2019-08-31 | $138.71M | -9.21% |
| 2019-05-31 | $152.78M | -1.87% |
| 2019-02-28 | $155.69M | 24.64% |
| 2018-11-30 | $124.91M | 0.20% |
| 2018-08-31 | $124.67M | -11.63% |
| 2018-05-31 | $141.08M | -5.52% |
| 2018-02-28 | $149.32M | 9.43% |
| 2017-11-30 | $136.46M | 10.62% |
| 2017-08-31 | $123.36M | -3.20% |
| 2017-05-31 | $127.43M | -6.69% |
| 2017-02-28 | $136.57M | 0.52% |
| 2016-11-30 | $135.87M | 2.62% |
| 2016-08-31 | $132.39M | -2.16% |
| 2016-05-31 | $135.31M | 4.09% |
| 2016-02-29 | $129.99M | -7.44% |
| 2015-11-30 | $140.44M | 8.04% |
| 2015-08-31 | $129.99M | -3.32% |
| 2015-05-31 | $134.45M | 0.62% |
| 2015-02-28 | $133.61M | 0.72% |
| 2014-11-30 | $132.66M | -4.23% |
| 2014-08-31 | $138.53M | 14.55% |
| 2014-05-31 | $120.93M | 10.46% |
| 2014-02-28 | $109.48M | -8.79% |
| 2013-11-30 | $120.03M | -5.03% |
| 2013-08-31 | $126.38M | 17.99% |
| 2013-05-31 | $107.11M | 4.94% |
| 2013-02-28 | $102.07M | -10.97% |
| 2012-11-30 | $114.65M | -2.73% |
| 2012-08-31 | $117.87M | 42.67% |
| 2012-05-31 | $82.62M | 12.71% |
| 2012-02-29 | $73.30M | -10.14% |
| 2011-11-30 | $81.57M | 1.88% |
| 2011-08-31 | $80.06M | 17.57% |
| 2011-05-31 | $68.10M | 4.84% |
| 2011-02-28 | $64.95M | -7.43% |
| 2010-11-30 | $70.17M | -4.55% |
| 2010-08-31 | $73.51M | 26.27% |
| 2010-05-31 | $58.22M | -4.47% |
| 2010-02-28 | $60.94M | 0.02% |
| 2009-11-30 | $60.93M | 4.82% |
| 2009-08-31 | $58.13M | 11.29% |
| 2009-05-31 | $52.24M | -27.20% |
| 2009-02-28 | $71.75M | 23.63% |
| 2008-11-30 | $58.04M | 7.66% |
| 2008-08-31 | $53.91M | -5.91% |
| 2008-05-31 | $57.30M | - |
Lifecore Biomedical generated $24.70M in revenue during Q1 2025, up -34.79% compared to the previous quarter, and up 78.31% compared to the same period a year ago.
Lifecore Biomedical Revenue Breakdown
Lifecore Biomedical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | May 24 |
|---|---|
| Product and Service, Other | - |
Latest
Quarterly Revenue by Product
| Product/Service | Feb 23 | Nov 22 |
|---|---|---|
| Other Segments | - | - |
Latest
Lifecore Biomedical Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Feb 23 | Nov 22 |
|---|---|---|
| CZECHIA | $700.00K | $1.00M |
| SWITZERLAND | $6.80M | $4.00M |
| IRELAND | $1.10M | $1.00M |
| AUSTRALIA | $1.10M | - |
| All Other Countries | $200.00K | $500.00K |
| CANADA | $700.00K | $2.60M |
Latest
Lifecore Biomedical's latest quarterly revenue breakdown by geography, as of Feb 23: SWITZERLAND (64.15%), IRELAND (10.38%), AUSTRALIA (10.38%), CZECHIA (6.60%), CANADA (6.60%), and All Other Countries (1.89%).
Lifecore Biomedical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CTLT | Catalent | $4.38B | $1.02B |
| TLRY | Tilray Brands | $788.94M | $200.04M |
| IRWD | Ironwood Pharmaceuticals | $442.74M | $91.59M |
| KMDA | Kamada | $144.76M | $37.40M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| DERM | Journey Medical | $79.18M | $14.86M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.09M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| AKAN | Akanda | $2.16M | $762.61K |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |